November 30, 2020 Open Accruing SARC Studies Open accruing studies for you to refer or enroll your patients: SARC024 for Rhabdomyosarcoma (alveolar and embryonal) and Mesenchymal Chondrosarcoma SARC031 for Unresectable or Metastatic NF1 Associated or Sporadic Malignant Peripheral Nerve … Read more
November 6, 2020 SARC Meeting at CTOS 2020 The SARC Meeting at the 2020 CTOS Virtual Annual Meeting will be held Wednesday, November 18 from 1:00–3:00 pm Eastern. Read more
September 30, 2020 From the SARC Board Chair: Dr. Ernest “Chappie” Conrad III Dear Sarcoma Partners and Advocates, The Sarcoma Alliance for Research Through Collaboration (SARC) was founded in 2003 with a mission of providing a collaborative infrastructure to make progress in the … Read more
September 25, 2020 Collaboration, Action, Evolution: SARC 2020 Progress Report On October 1 we will welcome our new President & CEO Steven Young. In addition, Dr. Chappie Conrad has begun his new role as Chair of the SARC Board of … Read more
September 2, 2020 SARC ANNOUNCES THE APPOINTMENT OF NEW LEADERSHIP With the decision of Denise Reinke earlier this year to step down from her roles as president and CEO and board chair, SARC is pleased to announce the successful recruitment … Read more
April 28, 2020 Message from SARC President and CEO, Denise Reinke This year will mark a change for SARC, as I have decided to step down as President & CEO. I have been privileged to be a part of SARC from … Read more
February 28, 2019 RARE DISEASE DAY 2019 Rare Disease Day 2019 was marked on February 28 around the world and at the NIH with a special day filled with opportunities to meet wonderful people committed to making … Read more
January 18, 2019 LILLY REPORTS RESULTS OF PHASE 3 SOFT TISSUE SARCOMA Today, Eli Lilly reported that the results of their Phase 3 study of olaratumab (LARTRUVO®) in combination with doxorubicin versus doxorubicin alone in patients with advanced or metastatic soft tissue … Read more
June 28, 2018 SARC Investigator-Initiated Osteosarcoma Study Shows Positive Results of Regorafenib SARC (Sarcoma Alliance for Research Through Collaboration) is pleased to report the positive results of their osteosarcoma trial of regorafenib. The goal of improving progression-free survival for patients receiving regorafenib … Read more
June 1, 2018 2018 CAREER DEVELOPMENT PROGRAM AWARD RECIPIENT ANNOUNCED CONGRATULATIONS ANUSHA KALBASI, MD SARC (Sarcoma Alliance for Research Through Collaboration) is pleased to announce Dr. Anusha Kalbasi as the 2018 SARC Career Development Program Award recipient. At the 2018 … Read more